Molecular and immunological features of a prolonged exceptional responder with malignant pleural mesothelioma treated initially and rechallenged with pembrolizumab
暂无分享,去创建一个
N. Tunariu | Juanita Lopez | U. Banerji | N. Fotiadis | M. O'Brien | J. D. de Bono | B. Gurel | S. Miranda | S. Carreira | J. Ang | S. Popat | W. Yuan | M. Crespo | I. Figueiredo | R. Riisnaes | A. Wotherspoon | A. Minchom | A. Ferreira | C. Bertan | Rita Pereira | Matt Clarke | C. Baker